LMRI
Get informed when a big investor buys or sells
+ FollowOvervalued by 218.7% based on the discounted cash flow analysis.
| Market cap | $904.12 Million |
|---|---|
| Enterprise Value | $1.82 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.66 |
| Beta | 2.18 |
| Outstanding Shares | 95,983,233 |
| P/E Ratio | -17.36 |
|---|---|
| PEG | 16.25 |
| Price to Sales | - |
| Price to Book Ratio | 1.57 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0.53 |
| Debt to Equity | 1.61 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 45.00%▲ 15.10% |
|---|---|
| Total Invested | $303.52M▼ 41.98% |
| Investors Holding | 90▲ 28.00% |
No data
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron e...